Evidence map›Paper›PMID 31811131›Full record

ArticleNature communications2019

Mapping lung cancer epithelial-mesenchymal transition states and trajectories with single-cell resolution.

Loukia G Karacosta, Benedict Anchang, Nikolaos Ignatiadis, Samuel C Kimmey, Jalen A Benson, Joseph B Shrager, Robert Tibshirani, Sean C Bendall, Sylvia K Plevritis

Abstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 129 papers.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

129 citing papers in PubMed.

  1. Review
  2. Article
  3. Reprogramming resistance in advanced lung cancer: epigenetic modulation to restore therapeutic vulnerability.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Loukia G KaracostaDepartment of Biomedical Data Science, Stanford University, Stanford, USA.
Benedict AnchangDepartment of Biomedical Data Science, Stanford University, Stanford, USA.
Nikolaos IgnatiadisDepartment of Statistics, Stanford University, Stanford, USA.
Samuel C KimmeyDepartment of Pathology, Stanford University, Stanford, USA.ORCID http://orcid.org/0000-0002-5742-4037
Jalen A BensonDepartment of Cardiothoracic Surgery, Stanford University, Stanford, USA.
Joseph B ShragerDepartment of Cardiothoracic Surgery, Stanford University, Stanford, USA.
Robert TibshiraniDepartment of Biomedical Data Science, Stanford University, Stanford, USA.
Sean C BendallDepartment of Pathology, Stanford University, Stanford, USA.ORCID http://orcid.org/0000-0003-1341-2453
Sylvia K PlevritisDepartment of Biomedical Data Science, Stanford University, Stanford, USA. sylvia.plevritis@stanford.edu.

Funding

Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI Melinda L. Telli · 2007 to 2026
$71.4M
Stanford Cancer Immune Monitoring and Analysis Center (CIMAC)U24CA224309 · NCI · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Holden T. Maecker · 2017 to 2026
$19.9M
Stanford/UNC Biomimetic U19 Research CenterU19AI116484 · NIAID · STANFORD UNIVERSITY · PI KUO, CALVIN J · 2015 to 2025
$13.5M
Spatial-Genomic Integrative Multi-Species Analysis of Lymph Node MetastasisU54CA209971 · NCI · STANFORD UNIVERSITY · PI NOLAN, GARRY P, PLEVRITIS, SYLVIA KATINA · 2016 to 2021
$11.0M
MIRIAD - Multiplexed Imaging of Resilience In Alzheimers DiseaseR01AG057915 · NIA · STANFORD UNIVERSITY · PI ANGELO, ROBERT MICHAEL, BENDALL, SEAN CURTIS · 2017 to 2021
$4.5M
The Phenotypic Landscape of Cognitive Decline as Revealed by Next-Generation Multiplexed Ion Beam ImagingR01AG056287 · NIA · STANFORD UNIVERSITY · PI ANGELO, ROBERT MICHAEL, BENDALL, SEAN CURTIS · 2017 to 2021
$2.6M
Cancer Systems Biology Scholars ProgramR25CA180993 · NCI · STANFORD UNIVERSITY · PI PLEVRITIS, SYLVIA KATINA · 2014 to 2018
$2.2M
A single-cell platform to discover and study regulators of human developmentR00GM104148 · NIGMS · STANFORD UNIVERSITY · PI BENDALL, SEAN CURTIS · 2014 to 2016
$747k
NCI NIH HHS P30 CA124435NCI NIH HHS R25 CA180993NCI NIH HHS U24 CA224309NCI NIH HHS U54 CA209971NIAID NIH HHS U19 AI116484NIA NIH HHS R01 AG056287NIA NIH HHS R01 AG057915NIGMS NIH HHS R00 GM104148U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) U54CA209971
6 · The paper itself

Abstract

Elucidating the spectrum of epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition (MET) states in clinical samples promises insights on cancer progression and drug resistance. Using mass cytometry time-course analysis, we resolve lung cancer EMT states through TGFβ-treatment and identify, through TGFβ-withdrawal, a distinct MET state. We demonstrate significant differences between EMT and MET trajectories using a computational tool (TRACER) for reconstructing trajectories between cell states. In addition, we construct a lung cancer reference map of EMT and MET states referred to as the EMT-MET PHENOtypic STAte MaP (PHENOSTAMP). Using a neural net algorithm, we project clinical samples onto the EMT-MET PHENOSTAMP to characterize their phenotypic profile with single-cell resolution in terms of our in vitro EMT-MET analysis. In summary, we provide a framework to phenotypically characterize clinical samples in the context of in vitro EMT-MET findings which could help assess clinical relevance of EMT in cancer in future studies.

Indexed as

AlgorithmsCell Line, TumorComputational BiologyCytophotometryEpithelial CellsEpithelial-Mesenchymal TransitionHumansLung NeoplasmsPhenotypeSystems BiologyTransforming Growth Factor betaTransforming Growth Factor beta

Identifiers

PMID31811131
PMCPMC6898514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.